Generic medicine

Basiliximab: Brands, Price & Uses in Bangladesh

Basiliximab is a chimeric (murine/human) monoclonal antibody that is FDA-approved for the following use: Established/approved use: Prophylaxis (prevention) of acute organ rejection in adult and…

Forms:IV Infusion

About Basiliximab

Indications of Basiliximab

Basiliximab is a chimeric (murine/human) monoclonal antibody that is FDA-approved for the following use:

  • Established/approved use: Prophylaxis (prevention) of acute organ rejection in adult and pediatric patients receiving renal (kidney) transplantation, when used as part of an immunosuppressive regimen that also includes a calcineurin inhibitor (such as cyclosporine) and corticosteroids.
  • Adjunct/combination requirement: Basiliximab is used only as an induction component added to a broader maintenance immunosuppressive regimen; it is not used alone.
  • Off-label/guideline-supported use: Some transplant centers use Basiliximab induction in other types of solid-organ transplantation (e.g., liver, heart, lung, pancreas) as part of institutional protocols; this is not an FDA-approved indication and should only be undertaken by a transplant specialist team.

Dosage & Administration of Basiliximab

Adult Dosing (Renal Transplantation)

DoseTiming
20 mg IVWithin 2 hours before transplant surgery (Day 0)
20 mg IV4 days after transplantation (Day 4)

Total course: two doses. If a severe hypersensitivity reaction or graft loss occurs, the second dose should not be given.

Pediatric Dosing

Body WeightDoseSchedule
Less than 35 kg10 mg IVDay 0 (pre-transplant) and Day 4 (post-transplant)
35 kg or more20 mg IVDay 0 (pre-transplant) and Day 4 (post-transplant)

Administration

Basiliximab is given only by a healthcare professional in a hospital/transplant center, as an intravenous infusion (diluted, over about 20-30 minutes) or as a slow IV bolus injection. It must be administered as part of an overall immunosuppressive regimen and only under the supervision of a physician experienced in transplant immunosuppression, in a facility equipped to manage severe hypersensitivity reactions.

Renal/Hepatic Impairment

No dose adjustment is established as required for renal or hepatic impairment based on available data; use in these patients requires individualized specialist judgment.

Side Effects of Basiliximab

Common Side Effects

  • Constipation, nausea, vomiting, diarrhea
  • Urinary tract infection
  • Hypertension or hypotension
  • Headache, tremor
  • Peripheral edema
  • Fever (pyrexia)
  • Surgical wound complications
  • Hyperkalemia, hypercholesterolemia
  • Anemia
  • Upper respiratory tract infection, dyspnea

Serious Side Effects

  • Severe acute hypersensitivity reactions, including anaphylaxis (see Precautions and Warnings)
  • Serious infections, including opportunistic infections
  • Malignancy, including post-transplant lymphoproliferative disorder (PTLD)
  • Capillary leak syndrome (rare)

Contraindications of Basiliximab

Basiliximab is contraindicated in patients with known hypersensitivity to basiliximab or to any component of the formulation.

Frequently Asked Questions about Basiliximab

What is Basiliximab used for?

Basiliximab is used to help prevent the body's immune system from rejecting a newly transplanted kidney. It is given as part of a combination immunosuppressive regimen that also includes drugs such as cyclosporine and corticosteroids.

How is Basiliximab given?

Basiliximab is given only by a doctor or nurse as an intravenous (into a vein) infusion or injection in a hospital or transplant center - two doses in total, one shortly before the transplant surgery and one four days afterward. It cannot be taken at home or by mouth.

What are the most serious risks of Basiliximab?

The most serious risks are severe allergic reactions (including anaphylaxis), which can occur with the first dose or with a later exposure, and an increased risk of infections and certain cancers (such as lymphoproliferative disorder) because Basiliximab works by suppressing the immune system. Basiliximab is only given in facilities equipped to manage these reactions.

Can Basiliximab be used during pregnancy or breastfeeding?

Basiliximab should be used in pregnancy only if the potential benefit clearly justifies the potential risk to the fetus, since untreated transplant rejection is itself dangerous; it should only be given under close specialist supervision. It is not known if Basiliximab passes into breast milk, so a physician should help decide whether to breastfeed or continue treatment, weighing the benefits of breastfeeding against the mother's medical need.

Who should not receive Basiliximab?

Basiliximab should not be given to anyone with a known hypersensitivity (allergy) to basiliximab or any ingredient in the product.

Can children receive Basiliximab?

Yes, Basiliximab is approved for pediatric kidney transplant recipients, with the dose calculated based on the child's body weight, given by a transplant specialist team. It is not established as safe and effective in infants under 1 year of age.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles